DWM
IBRX icon

Diversify Wealth Management’s ImmunityBio IBRX Stock Holding History

Diversify Wealth Management’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
14,896
+1,901
+15% +$14.4K ﹤0.01% 1222
2026
Q1 		$90.4K Buy
+12,995
New +$89K ﹤0.01% 1119

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diversify Wealth Management's IBRX Position: Q2 2026 in Review

Diversify Wealth Management increased its ImmunityBio (IBRX) stake by 15% in Q2 2026, buying an estimated $14.4K and bringing the position to 14,896 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Diversify Wealth Management first reported a position in IBRX in Q1 2026 and has held it in 2 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Diversify Wealth Management held 14,896 shares of ImmunityBio worth $104K as of Q2 2026.
  • Diversify Wealth Management bought 1,901 ImmunityBio shares in Q2 2026, an estimated $14.4K.
  • ImmunityBio made up ﹤0.01% of Diversify Wealth Management's portfolio in Q2 2026, its #1222 holding.
  • Diversify Wealth Management first reported a position in ImmunityBio in Q1 2026 and has held it in 2 quarters since.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.